Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database.


Journal

Pharmacoepidemiology and drug safety
ISSN: 1099-1557
Titre abrégé: Pharmacoepidemiol Drug Saf
Pays: England
ID NLM: 9208369

Informations de publication

Date de publication:
02 2019
Historique:
received: 23 11 2017
revised: 14 09 2018
accepted: 27 09 2018
pubmed: 6 11 2018
medline: 24 3 2020
entrez: 6 11 2018
Statut: ppublish

Résumé

Heart failure (HF) is a common, serious, and still poorly known illness, which might benefit from studies in claims databases. However, to provide reliable estimates, HF patients must be adequately identified. This validation study aimed to estimate the diagnostic accuracy of the International Classification of Diseases, Tenth Revision (ICD-10) codes I50.x, heart failure, in the French hospital discharge diagnoses database. This study was performed in two university hospitals, comparing recorded discharge diagnoses and electronic health records (EHRs). Patients with discharge ICD-10 codes 150.x were randomly selected. Their EHRs were reviewed to classify HF diagnosis as definite, potential, or miscoded based on the European Society of Cardiology diagnostic criteria, from which the codes' positive predictive value (PPV) was computed. To estimate sensitivity, patients with an EHR HF diagnosis were identified, and the presence of the I50.x codes was sought for in the hospital discharge database. Two hundred possible cases of HF were selected from the hospital discharge database, and 229 patients with an HF diagnosis were identified from the EHR. The PPV of I50.x codes was 60.5% (95% CI, 53.7%-67.3%) for definite HF and 88.0% (95% CI, 83.5%-92.5%) for definite/potential HF. The sensitivity of I50.x codes was 64.2% (95% CI, 58.0%-70.4%). PPV results were similar in both hospitals; sensitivity depended on the source of EHR: Departments of cardiology had a higher sensitivity than had nonspecialized wards. Diagnosis codes I50.x in discharge summary databases accurately identify patients with HF but fail to capture some of them.

Identifiants

pubmed: 30395375
doi: 10.1002/pds.4690
doi:

Types de publication

Journal Article Multicenter Study Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

194-200

Informations de copyright

© 2018 John Wiley & Sons, Ltd.

Auteurs

Pauline Bosco-Lévy (P)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Centre, Team Pharmacoepidemiology, Bordeaux, France.
Bordeaux PharmacoEpi, INSERM CIC1401, Bordeaux, France.

Stéphanie Duret (S)

CHU de Bordeaux, Bordeaux, France.

François Picard (F)

CHU de Bordeaux, Bordeaux, France.

Pierre Dos Santos (P)

CHU de Bordeaux, Bordeaux, France.

Etienne Puymirat (E)

Hôpital Européen Georges Pompidou, AP-HP, Paris, France.

Véronique Gilleron (V)

CHU de Bordeaux, Bordeaux, France.

Patrick Blin (P)

Bordeaux PharmacoEpi, INSERM CIC1401, Bordeaux, France.

Gilles Chatellier (G)

Hôpital Européen Georges Pompidou, AP-HP, Paris, France.

Vincent Looten (V)

Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
UMRS1138 Equipe 22, Université Paris Descartes, Paris, France.

Nicholas Moore (N)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Centre, Team Pharmacoepidemiology, Bordeaux, France.
Bordeaux PharmacoEpi, INSERM CIC1401, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH